Report Detail
Global (United States, European Union and China) Bio-Therapeutic Glycoproteins Market Research Report 2019-2025
- RnM3603999 |
- 19 July, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Bio-Therapeutic Glycoproteins are bioactive compounds with carbohydrates attached to proteins. Glycan is the specific site where carbohydrate attaches to proteins and process of production is called glycosylation. Bio-therapeutic glycoproteins produced with glycan moieties that are similar to natural mammal glycans. The most common types are glycosylation O-linked and N-linked that are mainly depends on protein sequence attachment. Carbohydrates linked to proteins through either α and β linkages. Glycosylation is an important process of bio-therapeutic glycoproteins because it is critically modulated into bioactivity, stability, solubility against proteolysis, yield, clearance rate from circulation and immunogenicity. The bio-therapeutic glycoproteins mainly produced by yeast expression systems, insect cells, mammalian systems, and plant-based expression systems. In yeast expression systems, yeast is cultured chemically to scale up fermentation to an industrial level. Yeast and human share same N-glycan's linkage. Insect cells represent an alternative system for expression of recombinant bio-therapeutic proteins. Later recombinant proteins are separated from insect cells. Mammalian Systems are used to produce complex bio-therapeutic glycoproteins. Most of the FDA approved bio-therapeutic glycoproteins derived from mammalian systems. Plant-based expression systems used for the scale-up production of glycoproteins. Among all systems, mammalian systems are well established in pharmaceuticals. Some examples of bio-therapeutic glycoproteins include tocilizumab, bevacizumab, adalimumab, etc.
The potential benefits of Bio-Therapeutic Glycoproteins have been a subject of rising industrial interest in the context of wide range application. So, far they include several protein classes like antisera, cytokines, clotting factors, hormones, enzymes and enzyme inhibitors have been best suited physiologically. The trend of industrial developments likely continues alongside with growing knowledge about the functions of bio-therapeutic glycoproteins. Bio-Therapeutic Glycoproteins are a fastest growing field in the pharmaceutical industry due to a wide range of applicability. The mammalian expression system is used to produce glycoproteins that coded with human-like glycans. Bio-Therapeutic glycoproteins represent an integrated treatment for most of the autoimmune disorders, cancers, replacement therapies like hormone and enzyme substituted. All these benefits of glycoproteins drive the robust growth of the Bio-Therapeutic Glycoproteins market.
In 2019, the market size of Bio-Therapeutic Glycoproteins is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Bio-Therapeutic Glycoproteins.
This report studies the global market size of Bio-Therapeutic Glycoproteins, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Bio-Therapeutic Glycoproteins sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Genentech
Hoffmann-La Roche
Genzyme Corp
Abbott Laboratories
Amgen
Biogen
Merck
GlaxoSmithKline
Novartis Pharmaceuticals Corp
Market Segment by Product Type
Antisera
Cytokines
Clotting Factors
Hormones
Enzymes
Enzyme Inhibitors
Market Segment by Application
Oncology and Haematology
Diabetes
Cardiology
Inflammatory Diseases
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Bio-Therapeutic Glycoproteins status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Bio-Therapeutic Glycoproteins manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Bio-Therapeutic Glycoproteins are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Bio-Therapeutic Glycoproteins Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Antisera
- 1.3.3 Cytokines
- 1.3.4 Clotting Factors
- 1.3.5 Hormones
- 1.3.6 Enzymes
- 1.3.7 Enzyme Inhibitors
- 1.4 Market Segment by Application
- 1.4.1 Global Bio-Therapeutic Glycoproteins Market Share by Application (2019-2025)
- 1.4.2 Oncology and Haematology
- 1.4.3 Diabetes
- 1.4.4 Cardiology
- 1.4.5 Inflammatory Diseases
- 1.4.6 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Bio-Therapeutic Glycoproteins Market Size
- 2.1.1 Global Bio-Therapeutic Glycoproteins Revenue 2014-2025
- 2.1.2 Global Bio-Therapeutic Glycoproteins Sales 2014-2025
- 2.2 Bio-Therapeutic Glycoproteins Growth Rate by Regions
- 2.2.1 Global Bio-Therapeutic Glycoproteins Sales by Regions 2014-2019
- 2.2.2 Global Bio-Therapeutic Glycoproteins Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Bio-Therapeutic Glycoproteins Sales by Manufacturers
- 3.1.1 Bio-Therapeutic Glycoproteins Sales by Manufacturers 2014-2019
- 3.1.2 Bio-Therapeutic Glycoproteins Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Bio-Therapeutic Glycoproteins Revenue by Manufacturers (2014-2019)
- 3.2.2 Bio-Therapeutic Glycoproteins Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Bio-Therapeutic Glycoproteins Market Concentration Ratio (CR5 and HHI)
- 3.3 Bio-Therapeutic Glycoproteins Price by Manufacturers
- 3.4 Key Manufacturers Bio-Therapeutic Glycoproteins Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Bio-Therapeutic Glycoproteins Market
- 3.6 Key Manufacturers Bio-Therapeutic Glycoproteins Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Antisera Sales and Revenue (2014-2019)
- 4.1.2 Cytokines Sales and Revenue (2014-2019)
- 4.1.3 Clotting Factors Sales and Revenue (2014-2019)
- 4.1.4 Hormones Sales and Revenue (2014-2019)
- 4.1.5 Enzymes Sales and Revenue (2014-2019)
- 4.1.6 Enzyme Inhibitors Sales and Revenue (2014-2019)
- 4.2 Global Bio-Therapeutic Glycoproteins Sales Market Share by Type
- 4.3 Global Bio-Therapeutic Glycoproteins Revenue Market Share by Type
- 4.4 Bio-Therapeutic Glycoproteins Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Bio-Therapeutic Glycoproteins Sales by Application
6 United States
- 6.1 United States Bio-Therapeutic Glycoproteins Breakdown Data by Company
- 6.2 United States Bio-Therapeutic Glycoproteins Breakdown Data by Type
- 6.3 United States Bio-Therapeutic Glycoproteins Breakdown Data by Application
7 European Union
- 7.1 European Union Bio-Therapeutic Glycoproteins Breakdown Data by Company
- 7.2 European Union Bio-Therapeutic Glycoproteins Breakdown Data by Type
- 7.3 European Union Bio-Therapeutic Glycoproteins Breakdown Data by Application
8 China
- 8.1 China Bio-Therapeutic Glycoproteins Breakdown Data by Company
- 8.2 China Bio-Therapeutic Glycoproteins Breakdown Data by Type
- 8.3 China Bio-Therapeutic Glycoproteins Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Bio-Therapeutic Glycoproteins Breakdown Data by Company
- 9.2 Rest of World Bio-Therapeutic Glycoproteins Breakdown Data by Type
- 9.3 Rest of World Bio-Therapeutic Glycoproteins Breakdown Data by Application
- 9.4 Rest of World Bio-Therapeutic Glycoproteins Breakdown Data by Countries
- 9.4.1 Rest of World Bio-Therapeutic Glycoproteins Sales by Countries
- 9.4.2 Rest of World Bio-Therapeutic Glycoproteins Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Genentech
- 10.1.1 Genentech Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
- 10.1.4 Bio-Therapeutic Glycoproteins Product Introduction
- 10.1.5 Genentech Recent Development
- 10.2 Hoffmann-La Roche
- 10.2.1 Hoffmann-La Roche Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
- 10.2.4 Bio-Therapeutic Glycoproteins Product Introduction
- 10.2.5 Hoffmann-La Roche Recent Development
- 10.3 Genzyme Corp
- 10.3.1 Genzyme Corp Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
- 10.3.4 Bio-Therapeutic Glycoproteins Product Introduction
- 10.3.5 Genzyme Corp Recent Development
- 10.4 Abbott Laboratories
- 10.4.1 Abbott Laboratories Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
- 10.4.4 Bio-Therapeutic Glycoproteins Product Introduction
- 10.4.5 Abbott Laboratories Recent Development
- 10.5 Amgen
- 10.5.1 Amgen Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
- 10.5.4 Bio-Therapeutic Glycoproteins Product Introduction
- 10.5.5 Amgen Recent Development
- 10.6 Biogen
- 10.6.1 Biogen Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
- 10.6.4 Bio-Therapeutic Glycoproteins Product Introduction
- 10.6.5 Biogen Recent Development
- 10.7 Merck
- 10.7.1 Merck Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
- 10.7.4 Bio-Therapeutic Glycoproteins Product Introduction
- 10.7.5 Merck Recent Development
- 10.8 GlaxoSmithKline
- 10.8.1 GlaxoSmithKline Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
- 10.8.4 Bio-Therapeutic Glycoproteins Product Introduction
- 10.8.5 GlaxoSmithKline Recent Development
- 10.9 Novartis Pharmaceuticals Corp
- 10.9.1 Novartis Pharmaceuticals Corp Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Bio-Therapeutic Glycoproteins
- 10.9.4 Bio-Therapeutic Glycoproteins Product Introduction
- 10.9.5 Novartis Pharmaceuticals Corp Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Bio-Therapeutic Glycoproteins Sales Channels
- 11.2.2 Bio-Therapeutic Glycoproteins Distributors
- 11.3 Bio-Therapeutic Glycoproteins Customers
12 Market Forecast
- 12.1 Global Bio-Therapeutic Glycoproteins Sales and Revenue Forecast 2019-2025
- 12.2 Global Bio-Therapeutic Glycoproteins Sales Forecast by Type
- 12.3 Global Bio-Therapeutic Glycoproteins Sales Forecast by Application
- 12.4 Bio-Therapeutic Glycoproteins Forecast by Regions
- 12.4.1 Global Bio-Therapeutic Glycoproteins Sales Forecast by Regions 2019-2025
- 12.4.2 Global Bio-Therapeutic Glycoproteins Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Bio-Therapeutic Glycoproteins. Industry analysis & Market Report on Bio-Therapeutic Glycoproteins is a syndicated market report, published as Global (United States, European Union and China) Bio-Therapeutic Glycoproteins Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Bio-Therapeutic Glycoproteins market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
